Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Obsidian Therapeutics to Present at Upcoming Investor Conferences

Obsidian Therapeutics,Inc.
Posted on: 19 Mar 18

Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company will participate in two upcoming investor conferences:

On Friday, March 23, 2018, at 11:30 a.m. ET, Michael Gilman, Ph.D., Chief Executive Officer, will present a company overview at BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference at the Millennium Broadway Hotel & Conference Center in New York, NY. A breakout session will follow the presentation at 12:00 noon.

On Tuesday, April 3, 2018, Dr. Gilman will also make a presentation on Obsidian at 3:15 p.m. ET at the Jefferies IO Cell Therapy Summit, an event focused on novel therapeutics in the immuno-oncology space, at the Boston Harbor Hotel in Boston.

About Obsidian Therapeutics

Obsidian Therapeutics is a biotechnology company developing next-generation cell and gene therapies with pharmacologic operating systems. Based upon founding work on destabilizing domains by Professor Thomas Wandless, a leading researcher in chemical and systems biology, Obsidian’s lead programs are CAR-T products that incorporate controllable functions for enhanced safety and efficacy. Obsidian was founded in 2015 by Atlas Venture and is funded by a strong syndicate of venture investors. The company is headquartered in Cambridge, Massachusetts. Please visit

View source version on

Business Wire

Last updated on: 19/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.